Dr. Clare Faul:

Certainly, the development and technology development in the cancer service is excellent. One area we need to look at is survivorship now that we have 65% to 70% long-term survivors. What impact does that have on their lives? That is of particular interest to us in radiation oncology, but also in general. We need to look at the impact on, for example, finance, jobs, psychology and family. That is an area we need to emphasise for the future. We are doing much better and improving our survival rates; now we need to make sure that the quality of life of our patients who survive cancer is optimised.